BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/18/2025 8:22:02 AM | Browse: 188 | Download: 1002
Publication Name World Journal of Transplantation
Manuscript ID 102287
Country Latvia
ISSN 2220-3230 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Transplantation
Manuscript Type Retrospective Cohort Study
Article Title Major adverse cardiovascular events and hyperuricemia as an effect-modifying factor in kidney transplant recipients
Manuscript Source Unsolicited Manuscript
All Author List Elizabete Junk, Lilian Tzivian, Inese Folkmane, Kristofs Folkmanis, Janis Jushinskis, Gunta Strazda, Valdis Folkmanis, Viktorija Kuzema and Aivars Petersons
ORCID
Author(s) ORCID Number
Inese Folkmane http://orcid.org/0009-0005-7231-9517
Valdis Folkmanis http://orcid.org/0009-0000-3493-9137
Funding Agency and Grant Number
Corresponding Author Inese Folkmane, MD, PhD, Professor, Centre of Nephrology, Pauls Stradiņš Clinical University Hospital, Pilsoņu 13, Riga LV-1002, Latvia. folkmane.inese@inbox.lv
Key Words Kidney transplantation; Hyperuricemia; Uric acid; Cardiovascular risk; Major adverse cardiovascular events; Effect modification by hyperuricemia; Hyperuricemia treatment
Core Tip The relationship between hyperuricemia (HU) and major adverse cardiovascular (CV) events (MACEs) after kidney transplantation (KT) remains a topic of contention. We investigated the association between potential CV risk factors related to KT and MACEs, and their potential modification by HU. A very high level (> 475 μmol/L) of uric acid was found to act as an effect-modifying factor for MACEs, especially when combined with other risk factors such as previous CV events and anemia. This study makes an innovative contribution to the field by demonstrating the role of HU as a modulating factor on MACEs after KT.
Publish Date 2025-04-18 08:22
Citation

Junk E, Tzivian L, Folkmane I, Folkmanis K, Jushinskis J, Strazda G, Folkmanis V, Kuzema V, Petersons A. Major adverse cardiovascular events and hyperuricemia as an effect-modifying factor in kidney transplant recipients. World J Transplant 2025; 15(3): 102287

URL https://www.wjgnet.com/2220-3230/full/v15/i3/102287.htm
DOI https://dx.doi.org/10.5500/wjt.v15.i3.102287
Full Article (PDF) WJT-15-102287-with-cover.pdf